Icotinib (Hydrochloride)

Product Name: Icotinib (Hydrochloride)
CAS No.: 1204313-51-8
Chemical Name: Icotinib (Hydrochloride)
Synonyms: CS-1906;CS-1016;Icotinib HCl;Icotinib (Hydrochloride);Icotinib Hydrochloride (BPI-2009);Icotinib (Hydrochloride) impurity;N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride;N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride Icotinib (Hydrochloride)
CBNumber: CB22624183
Molecular Formula: C22H22ClN3O4
Formula Weight: 427.89
MOL File: 1204313-51-8.mol

More

Less

Icotinib (Hydrochloride) Property

storage temp.: Store at -20°C
solubility: Soluble in DMSO
form: Powder

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More

Less

N-Bromosuccinimide Price

ChemScene

Product number: CS-0918
Product name: Icotinib(Hydrochloride)
Purity: 99.99%
Packaging: 5mg
Price: $70
Updated: 2021/12/16

ChemScene

Product number: CS-0918
Product name: Icotinib(Hydrochloride)
Purity: 99.99%
Packaging: 10mg
Price: $100
Updated: 2021/12/16

ApexBio Technology

Product number: A3482
Product name: IcotinibHydrochloride
Packaging: 5mg
Price: $190
Updated: 2021/12/16

ChemScene

Product number: CS-0918
Product name: Icotinib(Hydrochloride)
Purity: 99.99%
Packaging: 50mg
Price: $290
Updated: 2021/12/16

Medical Isotopes, Inc.

Product number: 110621
Product name: IcotinibHydrochloride
Packaging: 300mg
Price: $690
Updated: 2021/12/16

More

Less

Icotinib (Hydrochloride) Chemical Properties,Usage,Production

Clinical Use

Icotinib hydrochloride, developed by the Chinese pharmaceutical company Zhejiang Bata Pharma Inc., is a potent small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor for the treatment of non-small cell lung cancer (NSCLC). It was first approved by the SFDA of China, and launched under the brand name Conmana in the middle of 2011, representing an important milestone for Chinese pharmaceutical research and development. As the third EGFR-TKI drug targeting NSCLS therapy, icotinib hydrochloride possesses a similar structure to gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, OST & Roche). Interestingly, a randomized, double-blind phase III clinical study of icotinib versus gefitinib in 399 patients with advanced NSCLC demonstrated that icotinib provides similar efficacy to gefitinib, but with better tolerability in NSCLC patients previously treated with one or two chemotherapy agents.

Synthesis

Icotinib was prepared by a similar process approach to that of erlotinib. Beginning from commercially available 2,20-(ethylenedioxy)diethanol (162), bis-tosylation to 163, followed by bis-alkylation with commercially available catechol derivative 164 provided crown-4-ether 165 in 96% yield. Nitration of polyether 165 using concentrated nitric acid and concentrated sulfuric acid provided nitroarene 166 in 65% yield. Reduction of the nitroarene under catalytic hydrogenation conditions gave amine 167 in 85% yield. Condensation of the amine 167 with formamide in the presence of ammonium formate afforded quinazolinone 168 in 80% yield. The chlorination of 168 using POCl3 furnished quinazolyl chloride 169 in 77% yield. The treatment of chloride 169 with amine 170 followed by the HCl salt formation produced icotinib hydrochloride (XIV) in good yield.

target

EGFR

Icotinib (Hydrochloride) Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Icotinib (Hydrochloride) Suppliers

China 72 United States 10 Global 82

AdooQ BioScience, LLC

Tel: +1 (866) 930-6790
Fax: +1 (866) 333-9607
Email: info@adooq.com
Country: United States
ProdList: 2784
Advantage: 58

Target molecule Corp.

Tel: 857-239-0968
Fax: 857-239-8801
Email: service1@targetmol.com
Country: United States
ProdList: 2559
Advantage: 60

Musechem

Tel: +1-800-259-7612
Fax: +1-800-259-7612
Email: info@musechem.com
Country: United States
ProdList: 4662
Advantage: 60

TargetMol Chemicals Inc.

Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Country: United States
ProdList: 19892
Advantage: 58

InvivoChem

Tel: +1-708-310-1919 +1-13798911105
Fax: 708-557-7486
Email: sales@invivochem.cn
Country: United States
ProdList: 6393
Advantage: 58

Cckinase, Inc.

Tel: +1 (732)236-3202
Email: sales@cckinase.com
Country: United States
ProdList: 2738
Advantage: 58

BOC Sciences

Tel: +1-631-485-4226
Fax: 1-631-614-7828
Email: inquiry@bocsci.com
Country: United States
ProdList: 19553
Advantage: 58

Aladdin Scientific

Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Country: United States
ProdList: 52927
Advantage: 58

1204313-51-8, Icotinib (Hydrochloride)Related Search:

Rituximab Rivaroxaban Ginsengrootextract Anti-PDZ and LIM domain protein 1 Capecitabine Imatinib AZD-9291 Chidamide Panitumumab

CS-1906

CS-1016

Icotinib Hydrochloride (BPI-2009)

Icotinib (Hydrochloride)

N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride

N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride Icotinib (Hydrochloride)

Icotinib HCl

Icotinib (Hydrochloride) impurity

1204313-51-8

C22H21N3O4HCl

Inhibitors